drug

meropenem

1 story · latest Nov 4, 2026

Follow meropenem. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jul 2023 · NDA215212

Timeline

Innoviva's IST unit posts 45% U.S. sales growth as NUZOLVENCE launches

Nov 4Quarterly updateInnoviva, Inc.zoliflodacin

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.